市场调查报告书
商品编码
1465991
生命科学工具市场:按技术、产品、服务、实验室所有者、实验室规模、最终用户划分 - 2024-2030 年全球预测Life Science Tools Market by Technology, Product, Offerings, Lab Ownership, Lab Size, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
生命科学工具市场规模预计到2023年为2,039.3亿美元,到2024年达到2,261.4亿美元,预计到2030年将达到4,291.9亿美元,复合年增长率为11.21%。
生命科学是指研究生物的科学单位,例如生物学、植物学、动物学、微生物学、生理学和生物化学。生命科学研究使用各种设备、用品、试剂和其他服务。慢性病的全球流行要求改善疾病早期诊断的工具。有利的投资环境正在推动生命科学工具的使用,以加速生物技术的研究和开发,从而造福健康和医疗。然而,使用生命科学工具时的高成本以及品管问题可能会阻碍其在最终用途行业的采用。此外,基因组学和蛋白质组学在精准医学中的日益增长的应用以及生命科学工具的突破性进展预计将推动生命科学工具在最终用途行业的部署。
主要市场统计 | |
---|---|
基准年[2023] | 2039.3亿美元 |
预测年份 [2024] | 2261.4亿美元 |
预测年份 [2030] | 4291.9亿美元 |
复合年增长率(%) | 11.21% |
技术在细胞生物学技术中采用高解析度成像和单细胞分析工具
细胞生物学技术专注于研究细胞的生理特性、结构、细胞器、相互作用、生命週期、分裂和凋亡。这项研究需要癌症、遗传疾病和药物开发等领域的必要工具。在选择细胞生物学工具时,研究人员优先考虑高通量筛检、活细胞成像和单细胞分析功能。基因组技术涉及基因组的分析和操作。该领域的工具可以进行定序、基因型鉴定、基因表现分析等,以帮助了解疾病的遗传基础、个人化医疗和生物技术的进步。蛋白质体学技术涉及蛋白质体(生物体或系统产生的蛋白质的整个集合)及其功能的大规模研究。蛋白质体学技术是理解疾病机制、蛋白质交互作用和治疗标靶的基础。
最终用户:医院诊断和病患管理技术对生命科学工具的广泛需求
学术研究机构优先考虑可负担性、多功能性和最尖端科技来支援各种研究活动。他们的兴趣范围从基础研究到应用科学,需要准确可靠的工具。与商业组织不同,学术研究机构通常在预算紧张的情况下运作,并专注于提供价值和多功能性的设备。生物技术公司致力于创新,需要尖端的生命科学工具来用于药物发现、基因组学和蛋白质组学等研究和开发目的。合约研究和受託製造厂商(CRO/CMO) 优先考虑效率、扩充性和合规性,以支援其製药和生物技术客户的各种计划。该细分市场与生技公司通用需要高通量和合规性设备,但不同之处在于强调服务的广度,需要能够适应不同客户需求的工具。诊断实验室重视诊断工具的准确性、可靠性和速度,以支援患者照护决策。用于大规模测试的自动化系统和用于患者资料的资料管理系统至关重要。医院需要能够无缝整合到患者照护工作流程中的生命科学工具。这包括诊断设备、病患监测工具、测试设备等可靠且易于临床工作人员使用的设备。
区域洞察
生命科学工具市场以医疗和製药领域为主,基因组学、蛋白质组学、肿瘤学和诊断筛检的快速普及,主要企业不断开发先进的生命科学研究工具,此后在南北发展。核准和使用基因组和组织诊断测试的有利法规环境正在推动美洲生命科学工具市场的成长。增加研发 (R&D) 支出以推进医学研究,以及生物製药公司更多地采用创新和先进工具,正在推动亚太地区生命科学工具的使用。欧洲、中东和非洲地区对医疗保健和製药研发的投资增加、消费者对治疗慢性病的先进医疗保健产品的支出增加以及政府对生命科学和製药领域研发的支持预计将增加。持续的联盟、收购和数位技术的采用预计将增加产量,并促进生命科学工具市场的全球成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估生命科学工具市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对生命科学工具市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.生命科学工具市场的市场规模与预测是多少?
2.生命科学工具市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?
3.生命科学工具市场的技术趋势和法规结构是什么?
4.生命科学工具市场主要厂商的市场占有率是多少?
5. 进入生命科学工具市场的合适型态和策略手段是什么?
[184 Pages Report] The Life Science Tools Market size was estimated at USD 203.93 billion in 2023 and expected to reach USD 226.14 billion in 2024, at a CAGR 11.21% to reach USD 429.19 billion by 2030.
Life sciences refer to the unit of science that studies living organisms, including biology, botany, zoology, microbiology, physiology, and biochemistry. Various instruments, consumables, reagents, and other services are used to study life science. The prevalence of chronic diseases worldwide is raising the need for improved tools for the early diagnosis of diseases. The favorable investment landscape to accelerate R&D in the biotechnological sector for its implications in health and medicine facilitates using life science tools. However, the high cost of implementation and maintenance and the quality control issues associated with using life science tools may impede their adoption by the end-use industries. Moreover, the rising applications of genomics and proteomics for precision medicine and breakthrough advancements in life science tools are expected to encourage their deployment across the end-use industries.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 203.93 billion |
Estimated Year [2024] | USD 226.14 billion |
Forecast Year [2030] | USD 429.19 billion |
CAGR (%) | 11.21% |
Technology: Adoption of tools for higher-resolution imaging and single-cell analysis in cell biology technology
Cell biology technology focuses on studying cells' physiological properties, structure, organelles, interactions, life cycle, division, and apoptosis. This study requires tools essential for research in areas such as cancer, genetic diseases, and drug development. Researchers prioritize high-throughput screening, live cell imaging, and single-cell analysis capabilities when selecting cell biology tools. Genomic technology encompasses the analysis and manipulation of genomes. Tools in this segment enable sequencing, genotyping, gene expression analysis, and more, aiding in the understanding of genetic foundations of diseases, personalized medicine, and biotechnological advancements. Proteomics technology involves the large-scale study of proteomes (the entire set of proteins produced by an organism or system) and their functions. It is fundamental in understanding disease mechanisms, protein interactions, and therapeutic targets.
End-User: Broader requirement for life science tools in hospitals for diagnostics and patient management technologies
Academic research institutes prioritize affordability, versatility, and cutting-edge technology to support a variety of research activities. Their interests span basic research to applied science, necessitating tools that offer precision and reliability. Unlike commercial entities, academic institutes often operate under tighter budget constraints, focusing on equipment that offers both value and versatility. Biotechnology companies work on innovation, requiring state-of-the-art life science tools for R&D purposes, including drug discovery, genomics, and proteomics. Contract research/manufacturing organizations (CROs/CMOs) prioritize efficiency, scalability, and compliance as they handle diverse projects for pharmaceutical and biotech clients. This segment shares similarities with biotech companies regarding the need for high-throughput and compliance-ready equipment but differs in its focus on service breadth, requiring tools that are adaptable to varied client needs. Diagnostic labs emphasize accuracy, reliability, and speed in diagnostics tools to support patient care decisions. Automated systems for high-volume testing and data management systems for patient data are essential. Hospitals require life science tools that integrate seamlessly into patient care workflows. This includes diagnostic equipment, patient monitoring tools, and laboratory instruments that are reliable and easy to use for clinical staff.
Regional Insights
The life science tools market is evolving in the Americas owing to the highly valued medical and pharmaceutical sector, rapid adoption of genomics, proteomics, oncology, and diagnostic screening, and major players continuously developing advanced tools for life science research. A well-regulated environment for approvals and usage of genomic and tissue diagnostic tests is encouraging the life science tools market growth in the Americas. Increasing research and development (R&D) expenditure to advance medical research and the growing adoption of innovative and advanced tools among biopharmaceutical companies are facilitating the use of life science tools in the APAC region. Rising investments in research and development of healthcare and pharmaceutical products, growing consumer expenditure on advanced healthcare products to treat chronic diseases, and supportive government initiatives for life science and pharmaceutical sector development are expanding the utilization of life science tools in the EMEA region. The ongoing collaborations, acquisitions, and embracing of digital technologies can increase production and are expected to contribute to the growth of the life science tools market worldwide.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Life Science Tools Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Life Science Tools Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Life Science Tools Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux SA, Bruker Corporation, Cardinal Health, Inc., Carl Zeiss AG, Charles River Laboratories International, Inc., Danaher Corporation, Diagnostica Longwood S.L., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., GE Healthcare Technologies Inc., Genscript Biotech Corporation, Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Illumina, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., Luminex Corporation, Merck KGaA, Mettler-Toledo International Inc., New England Biolabs, Inc., Oxford Instruments PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Quest Diagnostics Incorporated, Repligen Corporation, Sartorius AG, SGS SA, Shimadzu Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Life Science Tools Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Life Science Tools Market?
3. What are the technology trends and regulatory frameworks in the Life Science Tools Market?
4. What is the market share of the leading vendors in the Life Science Tools Market?
5. Which modes and strategic moves are suitable for entering the Life Science Tools Market?
TABLE 341